Minghan Jia

654 total citations
21 papers, 394 citations indexed

About

Minghan Jia is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minghan Jia has authored 21 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minghan Jia's work include Cancer Genomics and Diagnostics (8 papers), Esophageal Cancer Research and Treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Minghan Jia is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Esophageal Cancer Research and Treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Minghan Jia collaborates with scholars based in China, United States and Taiwan. Minghan Jia's co-authors include Li Cao, Guochun Zhang, Lingzhu Wen, Yulei Wang, Chongyang Ren, Cheukfai Li, Jiali Lin, Bo Chen, Guangnan Wei and Hsiaopei Mok and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Sensors.

In The Last Decade

Minghan Jia

21 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minghan Jia China 10 206 133 127 102 51 21 394
Nikoletta Sidiropoulos United States 8 163 0.8× 76 0.6× 135 1.1× 114 1.1× 50 1.0× 21 336
Marco Brugia Italy 12 218 1.1× 117 0.9× 100 0.8× 128 1.3× 27 0.5× 31 354
Roberto Piciotti Italy 9 128 0.6× 86 0.6× 76 0.6× 50 0.5× 41 0.8× 15 317
Bangbo Zhao China 14 147 0.7× 205 1.5× 127 1.0× 52 0.5× 90 1.8× 43 435
A. Michelotti Italy 11 210 1.0× 67 0.5× 108 0.9× 100 1.0× 63 1.2× 15 372
Jiansheng Li China 12 144 0.7× 138 1.0× 72 0.6× 54 0.5× 77 1.5× 29 396
Jenny Brändstedt Sweden 11 165 0.8× 161 1.2× 120 0.9× 58 0.6× 68 1.3× 15 415
Yukari Ishiguro Japan 12 138 0.7× 148 1.1× 59 0.5× 91 0.9× 86 1.7× 19 364
Woo Young Sun South Korea 9 162 0.8× 82 0.6× 127 1.0× 56 0.5× 64 1.3× 23 358
Teruhide Ishigame Japan 12 141 0.7× 197 1.5× 132 1.0× 101 1.0× 61 1.2× 36 406

Countries citing papers authored by Minghan Jia

Since Specialization
Citations

This map shows the geographic impact of Minghan Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghan Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghan Jia more than expected).

Fields of papers citing papers by Minghan Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghan Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghan Jia. The network helps show where Minghan Jia may publish in the future.

Co-authorship network of co-authors of Minghan Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Minghan Jia. A scholar is included among the top collaborators of Minghan Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghan Jia. Minghan Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Hongcheng, et al.. (2025). A Two-Stage Time-Domain Equalization Method for Mitigating Nonlinear Distortion in Single-Carrier THz Communication Systems. Sensors. 25(15). 4825–4825. 1 indexed citations
2.
3.
Cao, Li, Chongyang Ren, Guochun Zhang, et al.. (2022). Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer. DNA and Cell Biology. 41(5). 521–538. 5 indexed citations
4.
Li, Cheukfai, Chongyang Ren, Lingzhu Wen, et al.. (2022). Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature. Clinical Medicine Insights Oncology. 16. 1353193840–1353193840. 1 indexed citations
5.
Zhang, Guochun, Chongyang Ren, Cheukfai Li, et al.. (2022). Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. BMC Medicine. 20(1). 142–142. 90 indexed citations
6.
Li, Kai, Li Cao, Cheukfai Li, et al.. (2022). Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer Medicine. 12(5). 5195–5208. 2 indexed citations
7.
Li, Cheukfai, Guochun Zhang, Yulei Wang, et al.. (2022). Spectrum of MAP3K1 mutations in breast cancer is luminal subtype‑predominant and related to prognosis. Oncology Letters. 23(2). 68–68. 6 indexed citations
8.
Jia, Minghan, Ning Liao, Bo Chen, et al.. (2021). PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing. Breast Cancer. 28(3). 644–652. 8 indexed citations
9.
Wen, Lingzhu, Guochun Zhang, Chongyang Ren, et al.. (2021). Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients. Cancer Management and Research. Volume 13. 3055–3065. 5 indexed citations
10.
Yang, Weixiong, Chang‐Han Chen, Minghan Jia, et al.. (2021). Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 641270–641270. 43 indexed citations
11.
Zhang, Shuishen, Minghan Jia, Xiaoli Cai, et al.. (2020). Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients. Frontiers in Oncology. 10. 586084–586084. 2 indexed citations
12.
Yang, Weixiong, Na You, Minghan Jia, et al.. (2020). Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer. 146. 327–334. 15 indexed citations
13.
Chen, Bo, Guochun Zhang, Guangnan Wei, et al.. (2020). Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine Related Cancer. 27(3). 153–162. 26 indexed citations
14.
Chen, Bo, Guochun Zhang, Xuerui Li, et al.. (2020). Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging. 12(4). 3140–3155. 36 indexed citations
15.
Cao, Li, Guochun Zhang, Yulei Wang, et al.. (2020). Abstract P5-08-22: Associations between MYC alterations and clinical pathological characteristics in Chinese patients and TCGA cohort. Cancer Research. 80(4_Supplement). P5–8. 1 indexed citations
16.
Yang, Weixiong, Chang‐Han Chen, Minghan Jia, et al.. (2020). Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. SSRN Electronic Journal. 2 indexed citations
17.
Shi, Yawei, Minghan Jia, Lixia Xu, et al.. (2019). miR‐96 and autophagy are involved in the beneficial effect of grape seed proanthocyanidins against high‐fat‐diet‐induced dyslipidemia in mice. Phytotherapy Research. 33(4). 1222–1232. 25 indexed citations
18.
Jia, Minghan, Yanxin Wu, Bo Lin, et al.. (2018). Meta‐analysis of the association between maternal subclinical hypothyroidism and gestational diabetes mellitus. International Journal of Gynecology & Obstetrics. 144(3). 239–247. 31 indexed citations
19.
Jia, Minghan, Shiyang Kang, Yaxiong Zhang, et al.. (2015). Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysis.. PubMed. 7(3). 455–61. 30 indexed citations
20.
Hong, Honghai, Ti Zhou, Shuhuan Fang, et al.. (2014). Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin. Breast Cancer Research and Treatment. 148(1). 61–72. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikoletta Sidiropoulos Breakdown of academic impact, for papers by Marco Brugia Breakdown of academic impact, for papers by Roberto Piciotti Breakdown of academic impact, for papers by Bangbo Zhao Breakdown of academic impact, for papers by A. Michelotti Breakdown of academic impact, for papers by Jiansheng Li Breakdown of academic impact, for papers by Jenny Brändstedt Breakdown of academic impact, for papers by Yukari Ishiguro Breakdown of academic impact, for papers by Woo Young Sun Breakdown of academic impact, for papers by Teruhide Ishigame
Rankless by CCL
2026